Comparative effectiveness of granulocyte colony-stimulating factors to prevent febrile neutropenia and related complications in cancer patients in clinical practice: A systematic review

Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
Sarah MitchellMiny Samuel

Abstract

Febrile neutropenia (FN) is a serious side-effect of myelosuppressive chemotherapy. Several clinical trials and observational studies have evaluated the effects of prophylactic granulocyte colony-stimulating factors (G-CSFs) on risk of FN and related complications; however, no systematic reviews have focused on effectiveness in routine clinical practice. Here, we perform a systematic review assessing the comparative effectiveness of prophylaxis with a long-acting G-CSF (pegfilgrastim) versus short-acting G-CSFs (filgrastim, lenograstim, and filgrastim biosimilars) in cancer patients in real-world clinical settings. A systematic review was performed based on a pre-specified protocol and was consistent with the Cochrane Collaboration Handbook (2009) and the Centre for Reviews and Dissemination's Guidance for Undertaking Reviews in Health Care (2011). MEDLINE, Embase, BIOSIS, Cumulative Index to Nursing and Allied Health Literature, and Cochrane Library databases were searched for articles published from January 2002 to June 2014. Congress databases (MASCC/ASCO/ESMO) and Google Scholar were searched for abstracts published from January 2012 to August 2014. Filgrastim (NEUPOGEN®), lenograstim and nivestim (a filgrastim biosimilar) ...Continue Reading

References

Jan 1, 1993·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·V Trillet-LenoirD Tomita
Dec 19, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M D GreenUNKNOWN International Pegfilgrastim 749 Study Group
Feb 24, 2006·The Annals of Pharmacotherapy·Derek WeyckerAndrew G Glass
May 10, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas J SmithAntonio C Wolff
Sep 12, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G von MinckwitzUNKNOWN German Breast Group
Aug 12, 2008·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Eric J IpJames Chan
Jan 30, 2009·Journal of the National Comprehensive Cancer Network : JNCCN·Gary H Lyman
Sep 3, 2009·Journal of Medical Economics·Dawn HershmanJennifer L Malin
Nov 26, 2010·Current Medical Research and Opinion·Hiangkiat TanJen Malin
Nov 26, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M S AaproUNKNOWN European Organisation for Research and Treatment of Cancer
Feb 22, 2011·Asia-Pacific Journal of Clinical Oncology·Alexandre ChanSoon Thye Lim
Dec 21, 2012·Expert Review of Pharmacoeconomics & Outcomes Research·Pierre RofailLeon E Cosler
Sep 19, 2014·World Journal of Gastrointestinal Oncology·Víctor M Castellano-MegíasFrancisco Colina-Ruizdelgado
Sep 19, 2014·World Journal of Gastrointestinal Oncology·Ambedkar Raj Kulandai VeluIlavarasi Sinduja
Oct 7, 2014·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Alena M PfeilZsolt Szabo
Oct 7, 2014·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Sol Cortés de MiguelInmaculada Vallejo-Rodríguez
Mar 31, 2015·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Li WangRichard Barron

❮ Previous
Next ❯

Citations

Sep 25, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J KlasterskyUNKNOWN ESMO Guidelines Committee
Jun 24, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·K BlackwellN Harbeck
Sep 7, 2019·Clinical Drug Investigation·Zaina T Al-Salama, Susan J Keam
Jun 20, 2016·The Medical Journal of Australia·Ian N Olver
May 8, 2018·Annals of Surgical Treatment and Research·Jihyoun LeeCheol Wan Lim
Mar 16, 2019·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Kamel LaribiRafik Diab
Oct 27, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Michał ZimeckiMarcin Mączyński
Mar 19, 2020·Molecular Medicine Reports·Li LiuXiangyang Xiong
Sep 19, 2020·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Hartmut LinkA Buchner
Jul 6, 2020·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Xiang LiJuan Xu
May 28, 2019·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Elif ArasSaadettin Kilickap
Nov 21, 2017·European Journal of Clinical Pharmacology·Isabel PuértolasMaría Del Tránsito Salvador
Oct 7, 2020·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Patrick R TilleulJames O Edwards
Nov 12, 2020·Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine·Wei WangYan Wang
Feb 18, 2021·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Lauren RoderMarc Hoffmann

❮ Previous
Next ❯

Software Mentioned

Google Scholar

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.